View in EDS HTML Full Text PDF Full Text

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.

Saved in:
Bibliographic Details
Title: One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.
Authors: Yousuf M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Fathima S; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Alsugair AKA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Wu SJ; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Abdelmagid MG; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Patel SP; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Faldu PC; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Abdelaziz RM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Csizmar CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Zepeda Mendoza CJ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Reichard KK; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Viswanatha DS; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., He R; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Patnaik MS; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. tefferi.ayalew@mayo.edu.
Source: Blood cancer journal [Blood Cancer J] 2026 Apr 04; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 04.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41935083
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yousuf+M%22">Yousuf M</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Fathima+S%22">Fathima S</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Alsugair+AKA%22">Alsugair AKA</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Wu+SJ%22">Wu SJ</searchLink>; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Abdelmagid+MG%22">Abdelmagid MG</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Patel+SP%22">Patel SP</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Faldu+PC%22">Faldu PC</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Abdelaziz+RM%22">Abdelaziz RM</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Csizmar+CM%22">Csizmar CM</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Mangaonkar+AA%22">Mangaonkar AA</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Zepeda+Mendoza+CJ%22">Zepeda Mendoza CJ</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Reichard+KK%22">Reichard KK</searchLink>; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Viswanatha+DS%22">Viswanatha DS</searchLink>; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22He+R%22">He R</searchLink>; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Pardanani+A%22">Pardanani A</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Gangat+N%22">Gangat N</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Patnaik+MS%22">Patnaik MS</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Tefferi+A%22">Tefferi A</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. tefferi.ayalew@mayo.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2026 Apr 04; Vol. 16 (1). <i>Date of Electronic Publication: </i>2026 Apr 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41935083
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-026-01500-3
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yousuf M
      – PersonEntity:
          Name:
            NameFull: Fathima S
      – PersonEntity:
          Name:
            NameFull: Alsugair AKA
      – PersonEntity:
          Name:
            NameFull: Wu SJ
      – PersonEntity:
          Name:
            NameFull: Abdelmagid MG
      – PersonEntity:
          Name:
            NameFull: Patel SP
      – PersonEntity:
          Name:
            NameFull: Faldu PC
      – PersonEntity:
          Name:
            NameFull: Abdelaziz RM
      – PersonEntity:
          Name:
            NameFull: Csizmar CM
      – PersonEntity:
          Name:
            NameFull: Mangaonkar AA
      – PersonEntity:
          Name:
            NameFull: Zepeda Mendoza CJ
      – PersonEntity:
          Name:
            NameFull: Reichard KK
      – PersonEntity:
          Name:
            NameFull: Viswanatha DS
      – PersonEntity:
          Name:
            NameFull: He R
      – PersonEntity:
          Name:
            NameFull: Pardanani A
      – PersonEntity:
          Name:
            NameFull: Gangat N
      – PersonEntity:
          Name:
            NameFull: Patnaik MS
      – PersonEntity:
          Name:
            NameFull: Tefferi A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 04
              Text: 2026 Apr 04
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1